T2 Biosystems: Is This Slump A Buy Opportunity? [Seeking Alpha]
T2 Biosystems, Inc. (TTOO)
Last t2 biosystems, inc. earnings: 2/24 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.t2biosystems.com/phoenix.zhtml?c=253528&p=irol-faq
Company Research
Source: Seeking Alpha
Summary In late May, T2 Biosystems ( TTOO ) had a major approval that saw its stock go from $6 range to $9 in a month. But soon enough, it slumped back to its pre-approval range. This keeps happening in biopharma, frustrating investors no end. Between entering the market and producing the first solid numbers, investors start losing confidence in the product, and the stock slumps. Each company has its own set of reasons for making investors lose confidence. In the case of TTOO is the fact that its otherwise excellent product involves a steep adaptation curve - meaning, hospitals and similar institutions need quite a few months to adopt the T2Bacteria Panel, which is why solid numbers were not reflected in the first earnings post the approval. Once we understand the specific benefits and competitive differentiations of the product, however, we feel that the market was too quick to judge. There’s a lot that’s good here, and the company clearly said in its second quarter earnin
Show less
Read more
Impact Snapshot
Event Time:
TTOO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TTOO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TTOO alerts
High impacting T2 Biosystems, Inc. news events
Weekly update
A roundup of the hottest topics
TTOO
News
- T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024GlobeNewswire
- T2 Biosystems shareholders vote to convert $15M CRG debt into equity [Seeking Alpha]Seeking Alpha
- T2 Biosystems Shareholders Vote for CRG Debt Conversion into EquityGlobeNewswire
- T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. [Yahoo! Finance]Yahoo! Finance
- T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.GlobeNewswire
TTOO
Sec Filings
- 4/22/24 - Form S-1
- 4/19/24 - Form SC
- 4/18/24 - Form 8-K
- TTOO's page on the SEC website